Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Jun 1;43(3):227-31.
doi: 10.14503/THIJ-14-4949. eCollection 2016 Jun.

Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment

Case Reports

Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment

Allan K Nguyen et al. Tex Heart Inst J. .

Abstract

A 4-year-old boy had a 15-mm atrial septal defect repaired percutaneously with use of an Amplatzer Septal Occluder. At age 16 years, he presented with a week's history of fever, chills, dyspnea, fatigue, and malaise. Cultures grew methicillin-sensitive Staphylococcus aureus. A transesophageal echocardiogram showed a 1.25 × 1.5-cm pedunculated mass on the left aspect of the atrial septum just superior to the mitral valve, and a smaller vegetation on the right inferior medial aspect of the septum. At surgery, visual examination of both sides of the septum revealed granulation tissue, the pedunculated mass, the small vegetation, and exposed metal wires that suggested incomplete endothelialization of the occluder. We removed the occluder and patched the septal defect. The patient returned to full activity after 4 months and was asymptomatic 3 years postoperatively. Our report reinforces the need for further investigation into prosthetic device endothelialization, endocarditis prophylaxis, and recommended levels of physical activity in patients whose devices might be incompletely endothelialized. In addition to reporting our patient's case, we review the medical literature on this topic.

Keywords: Biocompatible materials/metabolism; cardiac catheterization/instrumentation; endocarditis, bacterial/etiology/pathology/prevention & control; endothelial cells/metabolism; heart defects, congenital/therapy; heart valve prosthesis implantation/adverse effects/instrumentation/methods; prosthesis-related infections/etiology/therapy; septal occluder device/adverse effects; time factors; treatment failure.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Transesophageal echocardiogram shows a pedunculated mass (arrow) superior to the mitral valve. AS = atrial septum; LA = left atrium; LV = left ventricle; MV = mitral valve
Fig. 2
Fig. 2
Intraoperative photograph of the right septum shows an incompletely endothelialized Amplatzer Septal Occluder (arrow) and vegetation on its inferior medial border (arrowhead).
Fig. 3
Fig. 3
Intraoperative photograph of the left atrium (LA) shows the atrial septum and the Amplatzer Septal Occluder (ASO) retracted superiorly. The ASO's left disc is poorly endothelialized (arrow), and a pedunculated mass is visible above the mitral valve (arrowhead).

References

    1. Holzer R, Hijazi ZM. Interventional approach to congenital heart disease. Curr Opin Cardiol. 2004;19(2):84–90. - PubMed
    1. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997;42(4):388–93. - PubMed
    1. Masura J, Gavora P, Podnar T. Long-term outcome of trans-catheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol. 2005;45(4):505–7. - PubMed
    1. Podnar T, Martanovic P, Gavora P, Masura J. Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovasc Interv. 2001;53(3):386–91. - PubMed
    1. Cardoso CO, Rossi Filho RI, Machado PR, Francois LM, Horowitz ES, Sarmento-Leite R. Effectiveness of the Amplatzer device for transcatheter closure of an ostium secundum atrial septal defect [in Portuguese] Arq Bras Cardiol. 2007;88(4):384–9. - PubMed

Publication types

MeSH terms

Substances